Medical Group

Journal of Addiction Medicine and Therapeutic Science

ISSN: 2455-3484

DOI

CC By

Advertise with us
Journal Information
  • Volume/IssueClick here
  • Review ProcessDouble Blind
    • Publication lead time3 - 4 weeks
    • Indexing statusYes; Purview
    • Manuscript Processing ChargesClick here
    • Submission ChargesNo
    • Waiver policy for APCYes
    • Language of Full TextEnglish
    • Full-text formats availablePDF, HTML
  • Show +
Best Practices
  • Type of LicenseCreative Commons
  • Open AccessYes; Policy
    • Does the author retain unrestricted copyright?Yes
    • Does the author retain publishing rights?Yes
    • Permanent article identifierDOI (Digital Object Identifier)
  • Show +
Publisher Information

Editor-In-Chief

John Brick
John Brick

Intoxikon, USA

Email: johnbrick@intoxikon.com
Tel: 215 504-8004
Fax: 215 502-8002

More Info.

Editorial Board

Sharon Rabinovitz-Shenkar
Founder and Head
University of Haifa
Israel
sharonrs123@gmail.com
JAMTS

Research Interest: Psychology & Addiction; Neuroscience & Addiction; Psyhopharmacology & Addiction; Addictive Behaviors; Addiction & Criminology

More Info.
Seungwoo Kang
Department of Anesthesiology
The State University of New Jersey
USA
seungwoo.kang@rutgers.edu
JAMTS

Research Interest: Elucidation of the molecular mechanisms controlling pathological neuronal activity in addiction and depression, and its application to the relevant disease therapeutics

More Info.
Ling Li
Departments of Pathology and Pediatrics
University of Maryland School of Medicine
USA
ling001@aol.com
JAMTS

Research Interest: Drug related death, SIDS, sudden death in all kinds

More Info.
Pinhas N Dannon
Professor
Tel Aviv University
Israel
pinhasd@post.tau.ac.il
JAMTS

Research Interest: Dr. Dannon is internationally recognized for his research and publications in the psychiatric treatment of depression, panic disorder, and behavioral addictions, including kleptomania, Internet addiction, and pathological gambling.

More Info.
Isabel Cristina Cespedes
Neuroscience, Molecular Biology, Genetics
Federal University of Sao Paulo
Brazil
isabel.cespedes@unifesp.br
JAMTS

Research Interest: My research interest is associated with neurochemical factors and their correlation with environmental stimuli in the stress response, and how these factors are associated with vulnerability to drug abuse.

More Info.
Dubravka Svob Strac
Division of Molecular Medicine
Rudjer Boskovic Institute
Croatia
dsvob@irb.hr
JAMTS

Research Interest: Neuropharmacology, genetics, neurologic, psychiatric and neurodegenerative disorders, cell culture, animal models, patients

More Info.
Alexandre Valen
Assistant Professor
Department of Psychiatry and Mental Health
Universidade Federal Fluminense
Brazil
avalen@uol.com.br
JAMTS

Research Interest: violent behavior and mental disorder; sexual crimes and mental disorder; personality disorders and violent behaviour

More Info.
Sanju George
Addiction Psychiatry
Birmingham Solihull Mental Health NHS Foundation Trust
UK
Sanju.George@bsmhft.nhs.uk
JAMTS

Research Interest: Opiate addiction, gambling addiction, alcohol misuse, legal highs, addiction in young people, gambling in developing countries, etc

More Info.
Yury Evgeny Razvodovsky
Central Scientific Laboratory
Grodno State Medical University
Russia
yury_razvodovsky@mail.ru
JAMTS

Research Interest: epidemiology of suicides and alcohol/drugs-related problems in transitional society

More Info.
Ge Zhi-Dong
Assistant Professor
Department of Anesthesiology
Medical College of Wisconsin
USA
zdge@mcw.edu
JAMTS

Research Interest: Dr. Ge’s research focuses on protection of ischemic myocardium against ischemia and reperfusion injury. This includes the application of volatile anesthetics, adenosine receptor agonists, and ischemic preconditioning, the phenomenon in which myocardium exposed to brief, repeated periods of sublethal ischemia becomes resistant to the deleterious effects of ischemia or reperfusion. Recent evidence from this lab indicates thatgenetic modulation of GTP cyclohydrolase 1 to increase cardiac tetrahydrobiopterin and nitric oxide production can protect myocardium from ischemia and reperfusion injuryand preserve the ability of ischemic preconditioning to elicit cardioprotection that is impaired by hyperglycemia. Further investigations are being actively conducted, including the mechanisms underlying myocardial protection by overexpression of GTP cyclohydrolase 1 gene in the presence of hyperglycemia and diabetes and the potential of GTP cyclohydrolase 1 overexpression in reducing maladaptive myocardial remodeling followinginfarction in diabetic and nondiabetic myocardium.

More Info.
Dipanwita Ghose
Anesthesiology
Vanderbilt University
USA
dipanwita.ghose@Vanderbilt.edu
JAMTS

Research Interest: My research helps to identify the role of NAc circuitry and neural mechanisms underlying drug addiction.

More Info.
Keshen Li
Professor
Institute of Neurology
Guangdong Medical College
China
likeshen1971@126.com
JAMTS

Research Interest: Keshen Li’s current research focuses on identifying genetic variants that modulate the risk of Alzheimer’s disease and other neuropsychiatric disorders. For this purpose, his group combines genomic, genetic and bioinformatics approaches to gain predictive insights into these diseases. 

More Info.
Kenneth Blum
Department of Pharmacology
University of Texas Health Science Center
USA
drd2gene@gmail.com
JAMTS

In 1995 Dr. Blum retired from the University of Texas Health Science Center giving up tenure to enter the world of business and biotechnology. In the second year, acting as manager of 1899 Limited Liability Corporation, his first weight management product grossed in excess of 60 million retail. His company Cyberpharm has launched a weight loss system with Rexall/Showcase which was launched early 1999. Dr. Blum continues to publish research articles, writes books (twelve), lectures, and is actively applying for numerous patents in the field of molecular genetics & nutrition. Dr. Blum is very active as Scientific Director of the Path Medical Foundation and former co-founder and Vice President of the American College of Addictionology and Compulsive Disorders. Dr. Blum is co-founder and Chairman& CSO of Impact Genomics and Managing Partner of IGENE, LLC. He is currently Chief Scientific Officer of G&G HealthCare Services, Inc. and Genomics HealthCare, LLC.  His concept of Reward Deficiency Syndrome is being embraced by world leaders in science and is part of the DSM –V, and the DRD2 gene discovery has been confirmed in over 4,000 publications from laboratories all over the world. He serves as Editor –in-Chief Omics Journal of Genetic Syndromes & Gene Therapy, Journal of Addiction Research & Therapy and Genetic Diseases & Genetic Reports, and is currently serving on twelve other prestigious journal’s editorial Boards. He has recently accepted the position of Chief Scientific Officer of Journal operations, Aperito, Publishing House.  Currently he has been named Volunteer Full Professor of the Department of Psychiatry & McKnight Brain Institute University of Florida College of Medicine, Gainesville, Florida and Adjunct Research Professor, Human Integrated Services Unit University of Vermont Center for Clinical & Translational Science, College of Medicine, Burlington, VT. He currently serves as neuroscience advisor for Dominion Diagnostics, LLC North Kingstown Rhode Island; G &G Holistic Addiction Treatment center, North Miami Beach Florida and Malibu Beach Recovery Center, Malibu Beach, California. Many consider him as the “Father of Psychiatric Genetics” and “Father of Neuro- Nutrient Therapy”. Dr. Blum received the Life Time Achievement Award from the National Institute of Holistic Addiction Studies 2011, the 2012 Scientific Achievement Award in a Gala Celebrity Event, Miami Beach Florida and Best Abstract Award from the American Society of Anesthesiology and Pain. He and Mark Gold recently signed with Springer as Series editor for Neuroscience of Addiction: A Reference Work which includes four volumes to be published in 2015. Dr. Blum has been notified by Research Gate that is Reputation Score is higher than 97.5% of all scientists in the network to date scoring 40.5. He has also accepted a distinguished appointment of Scientific Advisory Board of NVP's newly formed and funded portfolio company. 

More Info.
Olena Zhabenko
Lee Kong Chian School of Medicine
Nanyang Technological University
Singapore
olena.zhabenko@gmail.com
JAMTS

Research Interest: Alcohol-dependence, insomnia, cognitive-behavior therapy for insomnia, Internet intervention and health effects of underground spaces.

More Info.
Ayan Ghoshal
Neuropharmacology
Vanderbilt University
USA
ayan.ghoshal@vanderbilt.edu
JAMTS

Research Interest: His recent focus is on gaining a better understanding the role of muscarinic receptors for cognitive dysfunctions in schizophrenia.

More Info.
View more

Role of an Anesthesiologist in Smoking Patients Undergoing Endoscopic Procedures

Published On: August 31, 2017 | Pages: 030 - 031

Author(s): Somchai Amornyotin*
View Article DOI: 10.17352/2455-3484.000023

Alcohol Calculations in Emergency and Forensic Medicine

Published On: July 14, 2017 | Pages: 024 - 029

Author(s): John Brick* and William Bennett
View Article DOI: 10.17352/2455-3484.000022

How the histamine N-methyltransferase inhibitor metoprine alleviates methamphetamine reward

Published On: May 12, 2017 | Pages: 016 - 023

Author(s): Nobue Kitanaka, Junichi Kitanaka*, F Scott Hall, Satoshi Okumura#, Tomoyuki Sakamoto#, George R Uhl and Motohiko Takemura
View Article DOI: 10.17352/2455-3484.000021

Substance Use and Relationship Functioning: A Parallel Process

Published On: April 10, 2017 | Pages: 011 - 015

Author(s): Keith Klostermann*, Theresa Mignone, Melissa Mahadeo, Emma Papagni and Rene A Jones
View Article DOI: 10.17352/2455-3484.000020

Substance Use among Adolescents in Spain: A Brief Report

Published On: March 14, 2017 | Pages: 007 - 010

Author(s): Arroyo A* and Coronas C
View Article DOI: 10.17352/2455-3484.000019

PTSD and Intimate Partner Violence: Clinical Considerations and Treatment Options

Published On: February 22, 2017 | Pages: 001 - 006

Author(s): Theresa Mignone, Emma Papagni, Melissa Mahadeo, Keith Klostermann* and Rene A Jones
View Article DOI: 10.17352/2455-3484.000018

An Examination of the Relationship between Socio-epidemiologic Factors and Positive Workplace Drug Tests in the United States

Published On: December 26, 2016 | Pages: 023 - 027

Author(s): James Wiiliam Price*
View Article DOI: 10.17352/2455-3484.000017

Time of Death Relative to Alcohol Use: Application of Brain: blood Ratios and Gastric Ethanol

Published On: December 17, 2016 | Pages: 019 - 022

Author(s): John Brick*
View Article DOI: 10.17352/2455-3484.000016

Ethnic Differences in Abstinence Self-Efficacy among Recovering Individuals

Published On: December 02, 2016 | Pages: 013 - 018

Author(s): Elbia Navarro, Josefina Alvarez, Richard Contreras, Leonard A Jason*
View Article DOI: 10.17352/2455-3484.000015

Role of Duloxetine as Adjuvant in Chemotherapy Induced Peripheral Neuropathic Pain-An Update

Published On: June 29, 2016 | Pages: 010 - 012

Author(s): Kalpajit Dutta, Rakesh Garg*
View Article DOI: 10.17352/2455-3484.000014
TOP